6-Minute Walk Test Assessment Via Mobile App

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorIzmir Democracy University

About this trial

This study aims to develop an Android-based 6-Minute Walk Test (6MWT) application to facilitate quick and efficient functional capacity assessment in clinical settings. The project will be carried out by a multidisciplinary team of software engineers and physiotherapists, with algorithms developed for both indoor and outdoor environments. As GPS signals may be lost indoors, the program will utilize the phone's gyroscope for distance measurement, while GPS signals will be used outdoors. The study will include healthy individuals aged 18-65, without any exercise restrictions. Participants' demographic data will be recorded, and the 6MWT will be conducted according to traditional protocols. During the test, parameters such as heart rate, oxygen saturation, and walking distance will be measured and compared with traditional methods. The Android application will provide auditory and vibration cues at the start and end of the test and will report health data in real-time. The data will be presented as mean ± standard deviation for continuous variables, and the test reliability will be assessed using the test-retest method. Results will be reported as age- and gender-adjusted z-scores for objective functional decline.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Not having a disease that prevents walking

To be able to use a smartphone

Disqualifiers

Exercise restriction for any reason

Pregnancy or any known cardiovascular, pulmonary, neurological, metabolic or haematological disease

Having any problem that prevents communication

Trial population

This study will be conducted with healthy individuals.

Trial design

Design model

Other

Time perspective

Other

Treatments tested in this trial

  • Walk Test-T

    Other intervention

    6MWT will be conducted according to traditional protocols. During the test, parameters such as heart rate, oxygen saturation, and walking distance will be measured and compared with traditional methods.

  • Walk Test-A

    Other intervention

    In order to develop Android-based 6DYT, the system will be designed with a multidisciplinary team consisting of software engineer and physiotherapist. In this programme, separate algorithms will be developed for indoor and outdoor environments so that individuals can be evaluated in a hospital environment, at home or in daily life. In indoor environments, the GPS signal is lost or there is not enough signal strength. For this reason, the programme will be developed so that the gyroscope of the phone can be used for distance measurement. GPS signals will be used outdoors. In this way, the physical activity level of the individual both in the hospital and in daily life will be measured.

Treatment groups

111 Participants
are divided into 2 treatment groups
Group A: WalkTest-T2 interventions
Group B: Walk Test-A2 interventions

Trial outcomes

Primary outcomes

1

6-Minute Walk Test

Before and after the test, participants' height, body weight, resting heart rate, oxygen saturation, blood pressure, Borg Dyspnea, and fatigue levels are assessed. The test follows American Thoracic Society (ATS) guidelines in a 30-meter covered corridor. At the start and end, participants receive audible and vibration cues. The app notifies the remaining time, and pulse oximeter data is displayed in real time. The practitioner can monitor walking distance, heart rate, and oxygen saturation. At the end of the test, results are reported to both the participant and practitioner. Additional data, including step count, cadence, and step symmetry, are also calculated.

Time frame
Before and up to 2 weeks
2

SpO2

In the evaluation, SpO2 will be measured with a Bluetooth pulse oximeter that sends synchronised information flow to the application at the beginning, middle, and end of 6 minutes. In addition, the application will report the average of the SpO2 obtained from the entire test.

Time frame
Before and up to 2 weeks
3

Modified Borg Scale

It is a scale commonly used to assess exertional dyspnoea severity and rest dyspnoea severity. It consists of ten items describing the severity of dyspnoea according to degrees. The fact that the severity of dyspnoea is defined in the Modified Borg Scale (MBS) makes it easier for patients to apply. In this scale, symptom intensity is displayed progressively in a 0-10 score, representing the "absence of dyspnea" and "maximum dyspnea" respectively. Higher scores mean a worse outcome.

Time frame
Before and up to 2 weeks
4

Walking distance

Walking distance measurement will be performed according to 6DYT protocols. It will also be compared with the data from the smartphone.

Time frame
Before and up to 2 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: